These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 17337692)
1. Are young infants treated with erythromycin at risk for developing hypertrophic pyloric stenosis? Maheshwai N Arch Dis Child; 2007 Mar; 92(3):271-3. PubMed ID: 17337692 [No Abstract] [Full Text] [Related]
2. Infantile hypertrophic pyloric stenosis in infants treated with azithromycin. Morrison W Pediatr Infect Dis J; 2007 Feb; 26(2):186-8. PubMed ID: 17259889 [TBL] [Abstract][Full Text] [Related]
9. From the Centers for Disease Control and Prevention. Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin--Knoxville, Tennessee, 1999. JAMA; 2000 Jan; 283(4):471-2. PubMed ID: 10659863 [No Abstract] [Full Text] [Related]
10. Association between exposure to macrolides and the development of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis. Abdellatif M; Ghozy S; Kamel MG; Elawady SS; Ghorab MME; Attia AW; Le Huyen TT; Duy DTV; Hirayama K; Huy NT Eur J Pediatr; 2019 Mar; 178(3):301-314. PubMed ID: 30470884 [TBL] [Abstract][Full Text] [Related]
11. Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin--Knoxville, Tennessee, 1999. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1999 Dec; 48(49):1117-20. PubMed ID: 10634345 [TBL] [Abstract][Full Text] [Related]
12. Very early exposure to erythromycin and infantile hypertrophic pyloric stenosis. Cooper WO; Griffin MR; Arbogast P; Hickson GB; Gautam S; Ray WA Arch Pediatr Adolesc Med; 2002 Jul; 156(7):647-50. PubMed ID: 12090829 [TBL] [Abstract][Full Text] [Related]
13. Hypertrophic pyloric stenosis in mono-ovular extremely preterm twins after use of erythromycin. Shoji H; Suganuma H; Daigo M; Shinohara K; Umezaki H; Shiga S; Shimizu T; Yamashiro Y Pediatr Int; 2008 Oct; 50(5):701-2. PubMed ID: 19261125 [No Abstract] [Full Text] [Related]
14. Prenatal prescription of macrolide antibiotics and infantile hypertrophic pyloric stenosis. Cooper WO; Ray WA; Griffin MR Obstet Gynecol; 2002 Jul; 100(1):101-6. PubMed ID: 12100810 [TBL] [Abstract][Full Text] [Related]
15. Erythromycin use during pregnancy in relation to pyloric stenosis. Louik C; Werler MM; Mitchell AA Am J Obstet Gynecol; 2002 Feb; 186(2):288-90. PubMed ID: 11854652 [TBL] [Abstract][Full Text] [Related]
16. Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors for infantile hypertrophic pyloric stenosis. Mahon BE; Rosenman MB; Kleiman MB J Pediatr; 2001 Sep; 139(3):380-4. PubMed ID: 11562617 [TBL] [Abstract][Full Text] [Related]
17. No association between macrolide treatment in infancy and later pyloric stenosis in Sweden. Ludvigsson JF; Lundholm C; Örtqvist AK; Almqvist C Eur J Epidemiol; 2016 Mar; 31(3):331-2. PubMed ID: 26694588 [No Abstract] [Full Text] [Related]
19. The difficulty in evaluating all findings in study on use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis. de Vries F BMJ; 2014 Aug; 349():g5201. PubMed ID: 25138170 [No Abstract] [Full Text] [Related]
20. Balancing competing risks: perinatal exposure to macrolides increases the risk of infantile hypertrophic pyloric stenosis. Honein MA; Cragan JD Evid Based Med; 2014 Dec; 19(6):239. PubMed ID: 25121565 [No Abstract] [Full Text] [Related] [Next] [New Search]